Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b)...

FDA Drug Recall #D-1445-2014 — Class III — July 11, 2014

Recall Summary

Recall Number D-1445-2014
Classification Class III — Low risk
Date Initiated July 11, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sandoz Inc
Location Princeton, NJ
Product Type Drugs
Quantity 781,000 extended release tablets

Product Description

Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.

Reason for Recall

Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.

Distribution Pattern

Nationwide

Lot / Code Information

Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16

Other Recalls from Sandoz Inc

Recall # Classification Product Date
D-0651-2025 Class II Cyclophosphamide Injection 500 mg/5 mL (100 mg/... Sep 5, 2025
D-0626-2025 Class II Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic ... Aug 13, 2025
D-0569-2025 Class I Cefazolin for Injection, USP, 1 gram per vial, ... Jun 27, 2025
D-0570-2025 Class I Buffered Penicillin G Potassium for Injection, ... Jun 27, 2025
D-0286-2022 Class I Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL,... Nov 17, 2021

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.